News

Researchers at Helmholtz Munich have received an award from Breakthrough T1D, a leading global type 1 diabetes (T1D) research and advocacy organization, to fund a new diabetes research project. The project will leverage advanced artificial…

Futuristic medical concept with red human lungs

SPACETIME, a consortium project involving Helmholtz Munich and coordinated by VU University Medical Center Amsterdam (VUMC), has received a 12 million euro grant from the EU Mission on Cancer call. Over the next five years, 15 partners across seven…

A study led by Lara Urban, Principal Investigator at Helmholtz AI and the Pioneer Campus at Helmholtz Munich and TUM Junior Fellow at the Technical University of Munich (TUM), has revealed a novel method for detecting hidden antibiotic resistance,…

Researchers around Prof. Fabian Theis from Helmholtz Munich and the Technical University of Munich (TUM), have developed CellRank 2, a new tool that promises to transform the way scientists study cells. This new method significantly improves our…

In this interview, Dr. Vincent Fortuin explains their new approach for reliable AI.

Prof. Dr. Dr. Fabian Theis, Head of the Computational Health Center at Helmholtz Munich and Chair of the Mathematical Modeling of Biological Systems at the Technical University of Munich, has been awarded a two-year grant of $400,000 for the project…

News

Helmholtz Munich Receives Award from Breakthrough T1D to Fund AI-driven Diabetes Research

12 Million Euro Grant Awarded to SPACETIME for Lung Cancer Research

Detecting Hidden Antibiotic Resistance With Real-Time-Genomics

Advancing Single-Cell Analysis With CellRank 2

Building Reliable AI

Funding Boosts Expansion of Key Biomedical Tools